Our publications keep professionals working across the public, private, and academic sectors informed on the most important developments and issues in health security and biosecurity.
Find an article or report by keywords:
Nat Biotechnol 2007;25(10):1084-1087
Letter on publisher's site: PDF
Your editorial in the June issue draws attention to some of the difficulties encountered by companies developing drugs and vaccines under the umbrella of the Bioshield program. We would like to draw attention to one particular impediment to progress—implementation of the US Food and Drug Administration (FDA) Animal Efficacy Rule (‘the Rule’) to facilitate development of medical countermeasures (that is, medicines and vaccines) for bioterrorism.
Letter on publisher's site: PDF